Foreword: Tort Law and Health Law: Intersections and Opportunities

Q3 Social Sciences
Stacey A. Tovino
{"title":"Foreword: Tort Law and Health Law: Intersections and Opportunities","authors":"Stacey A. Tovino","doi":"10.1515/JTL-2019-0005","DOIUrl":null,"url":null,"abstract":"The influence of tort law on some basic aspects of health law is well known. For example, a patient may sue a physician in negligence when the physician deviates from the standard of care with respect to the performance of a medical treatment, surgical procedure, or diagnostic examination. By further example, the battery cause of action may be appropriate when a physician performs a medical treatment or surgical procedure without any consent from the patient. Or, a patient may allege negligence when a physician obtains technical consent to treatment but fails to provide information sufficient to enable the patient to give informed consent. At the Association of American Law Schools (AALS) Annual Meeting held on January 4, 2019, in New Orleans, Louisiana, the AALS Section on Torts and Compensation Systems convened a panel featuring four distinguished speakers who examined other, less obvious ties and relationships between the fields of tort law and health law. Mark Rothstein, the Herbert F. Boehl Chair of Law and Medicine and the Founding Director of the Institute for Bioethics, Health Policy and Law at the University of Louisville School of Medicine, opened the panel. Professor Rothstein examined one of the most controversial and misunderstood issues in clinical genetics; that is, whether a physician has a duty in tort to warn a patient’s genetically at-risk relatives. Arguing that the physician’s patient, not the physician, is in the best ethical and legal position to issue warnings, Professor Rothstein recommended that physicians assist their patients by","PeriodicalId":39054,"journal":{"name":"Journal of Tort Law","volume":"12 1","pages":"5 - 7"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/JTL-2019-0005","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Tort Law","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/JTL-2019-0005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Social Sciences","Score":null,"Total":0}
引用次数: 0

Abstract

The influence of tort law on some basic aspects of health law is well known. For example, a patient may sue a physician in negligence when the physician deviates from the standard of care with respect to the performance of a medical treatment, surgical procedure, or diagnostic examination. By further example, the battery cause of action may be appropriate when a physician performs a medical treatment or surgical procedure without any consent from the patient. Or, a patient may allege negligence when a physician obtains technical consent to treatment but fails to provide information sufficient to enable the patient to give informed consent. At the Association of American Law Schools (AALS) Annual Meeting held on January 4, 2019, in New Orleans, Louisiana, the AALS Section on Torts and Compensation Systems convened a panel featuring four distinguished speakers who examined other, less obvious ties and relationships between the fields of tort law and health law. Mark Rothstein, the Herbert F. Boehl Chair of Law and Medicine and the Founding Director of the Institute for Bioethics, Health Policy and Law at the University of Louisville School of Medicine, opened the panel. Professor Rothstein examined one of the most controversial and misunderstood issues in clinical genetics; that is, whether a physician has a duty in tort to warn a patient’s genetically at-risk relatives. Arguing that the physician’s patient, not the physician, is in the best ethical and legal position to issue warnings, Professor Rothstein recommended that physicians assist their patients by
前言:侵权法与健康法:交集与机遇
侵权法对卫生法一些基本方面的影响是众所周知的。例如,当医生在医疗、外科手术或诊断检查方面偏离护理标准时,患者可能会以疏忽为由起诉医生。通过进一步的例子,当医生在没有得到患者任何同意的情况下进行医疗或外科手术时,电池作用原因可能是合适的。或者,当医生获得治疗的技术同意,但未能提供足够的信息使患者能够给予知情同意时,患者可能会声称存在疏忽。在2019年1月4日于路易斯安那州新奥尔良举行的美国法学院协会(AALS)年会上,AALS侵权和赔偿制度科召集了一个小组,由四位杰出的演讲者组成,他们研究了侵权法和健康法领域之间其他不太明显的联系和关系。Herbert F.Boehl法律与医学主席、路易斯维尔大学医学院生物伦理、卫生政策与法律研究所创始所长Mark Rothstein宣布小组开幕。Rothstein教授研究了临床遗传学中最具争议和误解的问题之一;也就是说,在侵权行为中,医生是否有义务警告患者的基因风险亲属。Rothstein教授认为,发出警告的最佳道德和法律地位是医生的病人,而不是医生,他建议医生通过以下方式帮助病人
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Tort Law
Journal of Tort Law Social Sciences-Law
CiteScore
0.70
自引率
0.00%
发文量
10
期刊介绍: The Journal of Tort Law aims to be the premier publisher of original articles about tort law. JTL is committed to methodological pluralism. The only peer-reviewed academic journal in the U.S. devoted to tort law, the Journal of Tort Law publishes cutting-edge scholarship in tort theory and jurisprudence from a range of interdisciplinary perspectives: comparative, doctrinal, economic, empirical, historical, philosophical, and policy-oriented. Founded by Jules Coleman (Yale) and some of the world''s most prominent tort scholars from the Harvard, Fordham, NYU, Yale, and University of Haifa law faculties, the journal is the premier source for original articles about tort law and jurisprudence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信